Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Country Report

Consumer Health in

Consumer Health in Switzerland

96 pages, Oct 2017

US$2,650

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Stagnation in consumer health

An ongoing reluctance to self-medicate, cross-border shopping and pressure on unit prices, thanks to the leading retailer Migros teaming up with Apotheke Zur Rose, led to stagnation in consumer health in Switzerland in current value terms in 2017. OTC products in particular registered a poor performance, since the tendency for Swiss consumers to resort to self-medication only at the onset of illness constrained consumer demand.

Migros expands into consumer health retailing

Migros is expanding into the retailing of consumer health products through a shop-in-shop concept with the online retailer Apotheke Zur Rose. Zur Rose pharmacies opened in 50 Migros grocery outlets in mid-2017.

Crossing the border for weekly shopping

Cross-border shopping impacts consumer health, since Swiss consumers are aware that the prices of many consumer health products in Switzerland are often at least double the prices in neighbouring countries Germany, France and Italy. This motivates many to cross the border to take advantage of the weak euro and the strong Swiss franc and to purchase their consumer health requirements with their weekly shopping in a neighbouring country.

Consumer trust in leading brands

Despite the challenging economic conditions, Swiss consumers continued to put their trust in leading brands in 2017. The Swiss value tradition, and therefore the trust and loyalty in premium brands from leading multinationals, large domestic companies and European companies is strong.

Moderate growth expected

The growth of the Swiss economy is expected to continue at a stable but slower pace in 2018. The jobs market is set to remain strong, and the unemployment rate is expected to drop.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Consumer Health Sample Report Consumer Health Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples: (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Switzerland with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Switzerland, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Switzerland for free:

The Consumer Health in Switzerland market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Consumer Health in Switzerland?
What are the major brands in Switzerland?
What are the main trends in OTC Healthcare?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Consumer Health in Switzerland

EXECUTIVE SUMMARY

Stagnation in consumer health

Migros expands into consumer health retailing

Crossing the border for weekly shopping

Consumer trust in leading brands

Moderate growth expected

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 2 Life Expectancy at Birth 2012-2017

MARKET DATA

Table 3 Sales of Consumer Health by Category: Value 2012-2017
Table 4 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 5 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 6 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
Table 8 Distribution of Consumer Health by Format: % Value 2012-2017
Table 9 Distribution of Consumer Health by Format and Category: % Value 2017
Table 10 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

Summary 1 OTC: Switches 2016-2017

SOURCES

Summary 2 Research Sources

Analgesics in Switzerland

HEADLINES

PROSPECTS

Sluggish demand for systemic analgesics

The use of topical products is widespread

Strong forecast for topical analgesics/anaesthetic

COMPETITIVE LANDSCAPE

High concentration in analgesics

Product maturity slows growth

Low number of new product launches

CATEGORY DATA

Table 12 Sales of Analgesics by Category: Value 2012-2017
Table 13 Sales of Analgesics by Category: % Value Growth 2012-2017
Table 14 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
Table 15 NBO Company Shares of Analgesics: % Value 2013-2017
Table 16 LBN Brand Shares of Analgesics: % Value 2014-2017
Table 17 Forecast Sales of Analgesics by Category: Value 2017-2022
Table 18 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022

Cough, Cold and Allergy (Hay Fever) Remedies in Switzerland

HEADLINES

PROSPECTS

Seasonal trends remain the key driver of sales

Swiss consumers take soft remedies to treat colds

Prevention of the common cold proves important

COMPETITIVE LANDSCAPE

The leading companies have the best opportunities

Fragmented environment

New products have a traditional angle

CATEGORY DATA

Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2012-2017
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2012-2017
Table 21 Sales of Decongestants by Category: Value 2012-2017
Table 22 Sales of Decongestants by Category: % Value Growth 2012-2017
Table 23 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2013-2017
Table 24 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2017
Table 25 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
Table 26 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022

Dermatologicals in Switzerland

HEADLINES

PROSPECTS

Competition from cosmetic products limits value growth

Consumers turn to prescription medication

Stagnation expected in the forecast period

COMPETITIVE LANDSCAPE

Concentration prevails, led by Bayer AG

Galderma Schweiz AG strengthens its position

The rest of the market is fragmented

CATEGORY DATA

Table 27 Sales of Dermatologicals by Category: Value 2012-2017
Table 28 Sales of Dermatologicals by Category: % Value Growth 2012-2017
Table 29 NBO Company Shares of Dermatologicals: % Value 2013-2017
Table 30 LBN Brand Shares of Dermatologicals: % Value 2014-2017
Table 31 LBN Brand Shares of Hair Loss Treatments: % Value 2014-2017
Table 32 Forecast Sales of Dermatologicals by Category: Value 2017-2022
Table 33 Forecast Sales of Dermatologicals by Category: % Value Growth 2017-2022

Dietary Supplements in Switzerland

HEADLINES

PROSPECTS

The preference shifts to expensive products

Individualisation is a strong trend

Combination products enjoy popularity

COMPETITIVE LANDSCAPE

A traditional company is the leader

The category is fragmented

CATEGORY DATA

Summary 3 Dietary Supplements: Brand Ranking by Positioning 2017
Table 34 Sales of Dietary Supplements by Category: Value 2012-2017
Table 35 Sales of Dietary Supplements by Category: % Value Growth 2012-2017
Table 36 Sales of Dietary Supplements by Positioning: % Value 2012-2017
Table 37 Sales of Fish Oils/Omega Fatty Acids by Type: % Value 2012-2017
Table 38 NBO Company Shares of Dietary Supplements: % Value 2013-2017
Table 39 LBN Brand Shares of Dietary Supplements: % Value 2014-2017
Table 40 Forecast Sales of Dietary Supplements by Category: Value 2017-2022
Table 41 Forecast Sales of Dietary Supplements by Category: % Value Growth 2017-2022

Digestive Remedies in Switzerland

HEADLINES

PROSPECTS

Swiss consumers adopt natural ways to tackle digestive problems

The H2 blockers category ceases to exist in Switzerland

An acute outbreak of Norovirus pushes the growth of diarrhoeal remedies

COMPETITIVE LANDSCAPE

Multinationals lead digestive remedies

Traditional companies play an important role

Private label remains stable

CATEGORY DATA

Table 42 Sales of Digestive Remedies by Category: Value 2012-2017
Table 43 Sales of Digestive Remedies by Category: % Value Growth 2012-2017
Table 44 NBO Company Shares of Digestive Remedies: % Value 2013-2017
Table 45 LBN Brand Shares of Digestive Remedies: % Value 2014-2017
Table 46 Forecast Sales of Digestive Remedies by Category: Value 2017-2022
Table 47 Forecast Sales of Digestive Remedies by Category: % Value Growth 2017-2022

Eye Care in Switzerland

HEADLINES

PROSPECTS

Modern lifestyles support the rise in eye conditions

Swiss consumers adopt a daily eye care regime

Rising demand for eye health supplements is not expected to cannibalise eye care

COMPETITIVE LANDSCAPE

Eye care is highly concentrated

Fragmentation in the rest of the category

CATEGORY DATA

Table 48 Sales of Eye Care by Category: Value 2012-2017
Table 49 Sales of Eye Care by Category: % Value Growth 2012-2017
Table 50 Sales of Standard Eye Care by Format: % Value 2012-2017
Table 51 Sales of Standard Eye Care by Positioning: % Value 2012-2017
Table 52 NBO Company Shares of Eye Care: % Value 2013-2017
Table 53 LBN Brand Shares of Eye Care: % Value 2014-2017
Table 54 Forecast Sales of Eye Care by Category: Value 2017-2022
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2017-2022

Herbal/Traditional Products in Switzerland

HEADLINES

PROSPECTS

Herbal medication works too slowly for Swiss consumers

New status for herbal medicine

Some categories benefit from Swiss traditions

COMPETITIVE LANDSCAPE

Traditional companies have a strong presence

Low presence of multinationals

CATEGORY DATA

Table 56 Sales of Herbal/Traditional Products by Category: Value 2012-2017
Table 57 Sales of Herbal/Traditional Products by Category: % Value Growth 2012-2017
Table 58 NBO Company Shares of Herbal/Traditional Products: % Value 2013-2017
Table 59 LBN Brand Shares of Herbal/Traditional Products: % Value 2014-2017
Table 60 Forecast Sales of Herbal/Traditional Products by Category: Value 2017-2022
Table 61 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2017-2022

NRT Smoking Cessation Aids in Switzerland

HEADLINES

PROSPECTS

More consumers try quitting smoking, with positive results for NRT smoking cessation aids

Cross border-shopping affects the absolute category size

Convenience is a key driver

COMPETITIVE LANDSCAPE

High concentration

The leading players are vital to growth in the category

CATEGORY INDICATORS

Table 62 Number of Smokers by Gender 2012-2017

CATEGORY DATA

Table 63 Sales of NRT Smoking Cessation Aids by Category: Value 2012-2017
Table 64 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2012-2017
Table 65 Sales of NRT Gum by Flavour: % Value 2012-2017
Table 66 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2013-2017
Table 67 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2014-2017
Table 68 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022
Table 69 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022

Paediatric Consumer Health in Switzerland

HEADLINES

PROSPECTS

Parents are reluctant to administer medication

Low growth in the child population

Some categories perform better than others

COMPETITIVE LANDSCAPE

Leading companies restrict their paediatric consumer health ranges

The choice of brands is limited

CATEGORY DATA

Table 70 Sales of Paediatric Consumer Health by Category: Value 2012-2017
Table 71 Sales of Paediatric Consumer Health by Category: % Value Growth 2012-2017
Table 72 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2014-2017
Table 73 NBO Company Shares of Paediatric Consumer Health: % Value 2013-2017
Table 74 LBN Brand Shares of Paediatric Consumer Health: % Value 2014-2017
Table 75 Forecast Sales of Paediatric Consumer Health by Category: Value 2017-2022
Table 76 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2017-2022

Sleep Aids in Switzerland

HEADLINES

PROSPECTS

Stressful lifestyles increase the demand for sleep aids

Consumers are cautious about sleep aids

Consumers prefer soft remedies to treat sleep disorders

COMPETITIVE LANDSCAPE

Traditional companies have a strong presence

Low presence of multinationals

CATEGORY DATA

Table 77 Sales of Sleep Aids: Value 2012-2017
Table 78 Sales of Sleep Aids: % Value Growth 2012-2017
Table 79 NBO Company Shares of Sleep Aids: % Value 2013-2017
Table 80 LBN Brand Shares of Sleep Aids: % Value 2014-2017
Table 81 Forecast Sales of Sleep Aids: Value 2017-2022
Table 82 Forecast Sales of Sleep Aids: % Value Growth 2017-2022

Sports Nutrition in Switzerland

HEADLINES

PROSPECTS

Sports nutrition broadens its market potential

New product innovations make sports nutrition interesting

Convenience drives growth

COMPETITIVE LANDSCAPE

Switzerland is a difficult market to crack

High concentration in sports nutrition

CATEGORY DATA

Table 83 Sales of Sports Nutrition by Category: Value 2012-2017
Table 84 Sales of Sports Nutrition by Category: % Value Growth 2012-2017
Table 85 NBO Company Shares of Sports Nutrition: % Value 2013-2017
Table 86 LBN Brand Shares of Sports Nutrition: % Value 2014-2017
Table 87 Forecast Sales of Sports Nutrition by Category: Value 2017-2022
Table 88 Forecast Sales of Sports Nutrition by Category: % Value Growth 2017-2022

Vitamins in Switzerland

HEADLINES

PROSPECTS

Functional foods pose a challenge

Multivitamins are more popular

Convenience influences the purchasing decision

COMPETITIVE LANDSCAPE

High value share in the hands of a few companies

New product launches in vitamins

CATEGORY DATA

Summary 4 Multivitamins: Brand Ranking by Positioning 2017
Table 89 Sales of Vitamins by Category: Value 2012-2017
Table 90 Sales of Vitamins by Category: % Value Growth 2012-2017
Table 91 Sales of Multivitamins by Positioning: % Value 2012-2017
Table 92 NBO Company Shares of Vitamins: % Value 2013-2017
Table 93 LBN Brand Shares of Vitamins: % Value 2014-2017
Table 94 Forecast Sales of Vitamins by Category: Value 2017-2022
Table 95 Forecast Sales of Vitamins by Category: % Value Growth 2017-2022

Weight Management and Wellbeing in Switzerland

HEADLINES

PROSPECTS

A move towards healthier lifestyles, rather than weight management and wellbeing

Mixed messages within weight management and wellbeing

Spending cutbacks likely to impact growth

COMPETITIVE LANDSCAPE

The category is highly fragmented

Almased leads as Herbalife continues to lose share

Lack of multinationals to lead to stagnation

CATEGORY DATA

Table 96 Sales of Weight Management and Wellbeing by Category: Value 2012-2017
Table 97 Sales of Weight Management and Wellbeing by Category: % Value Growth 2012-2017
Table 98 NBO Company Shares of Weight Management and Wellbeing: % Value 2013-2017
Table 99 LBN Brand Shares of Weight Management and Wellbeing: % Value 2014-2017
Table 100 Forecast Sales of Weight Management and Wellbeing by Category: Value 2017-2022
Table 101 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2017-2022

Wound Care in Switzerland

HEADLINES

PROSPECTS

Low-value products and maturity erode the potential of the category

Retailers offer wound care products

Leading brands target the value-added segment

COMPETITIVE LANDSCAPE

High concentration in wound care

Premiumisation is the way forward

Less investment for OTC wound care

CATEGORY DATA

Table 102 Sales of Wound Care by Category: Value 2012-2017
Table 103 Sales of Wound Care by Category: % Value Growth 2012-2017
Table 104 NBO Company Shares of Wound Care: % Value 2013-2017
Table 105 LBN Brand Shares of Wound Care: % Value 2014-2017
Table 106 Forecast Sales of Wound Care by Category: Value 2017-2022
Table 107 Forecast Sales of Wound Care by Category: % Value Growth 2017-2022

Why buy this report?

Want to find out more about this report?

Request more information

Megatrends

Country Report

Consumer Health in Switzerland

New Report Guarantee

Executive Summary

New Report Guarantee

Stagnation in consumer health

Migros expands into consumer health retailing

Crossing the border for weekly shopping

Consumer trust in leading brands

Moderate growth expected

Samples

Overview

Why buy this report?

Samples: (FAQs about samples):

Want to find out more about this report?

Table of Contents

Consumer Health in Switzerland

EXECUTIVE SUMMARY

Stagnation in consumer health

Migros expands into consumer health retailing

Crossing the border for weekly shopping

Consumer trust in leading brands

Moderate growth expected

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

Analgesics in Switzerland

HEADLINES

PROSPECTS

Sluggish demand for systemic analgesics

The use of topical products is widespread

Strong forecast for topical analgesics/anaesthetic

COMPETITIVE LANDSCAPE

High concentration in analgesics

Product maturity slows growth

Low number of new product launches

CATEGORY DATA

Cough, Cold and Allergy (Hay Fever) Remedies in Switzerland

HEADLINES

PROSPECTS

Seasonal trends remain the key driver of sales

Swiss consumers take soft remedies to treat colds

Prevention of the common cold proves important

COMPETITIVE LANDSCAPE

The leading companies have the best opportunities

Fragmented environment

New products have a traditional angle

CATEGORY DATA

Dermatologicals in Switzerland

HEADLINES

PROSPECTS

Competition from cosmetic products limits value growth

Consumers turn to prescription medication

Stagnation expected in the forecast period

COMPETITIVE LANDSCAPE

Concentration prevails, led by Bayer AG

Galderma Schweiz AG strengthens its position

The rest of the market is fragmented

CATEGORY DATA

Dietary Supplements in Switzerland

HEADLINES

PROSPECTS

The preference shifts to expensive products

Individualisation is a strong trend

Combination products enjoy popularity

COMPETITIVE LANDSCAPE

A traditional company is the leader

The category is fragmented

CATEGORY DATA

Digestive Remedies in Switzerland

HEADLINES

PROSPECTS

Swiss consumers adopt natural ways to tackle digestive problems

The H2 blockers category ceases to exist in Switzerland